(646)792-7476 (702)533-2691

(646)792-7476
(702)533-2691

Ask A Doctor
Book a Consultation
Ask A Doctor
Book a Consultation

MANUSCRIPTS

  1. Sher G. Accidental Hemorrhage and Fetal Prognosis. South African Medical Journal
    1974; 48:764.
  2. Sher G. Trasylol in Cases of Accidental Hemorrhage with Coagulation Disorder and Associated Uterine Inertia. South African Medical Journal 1974; 48:1452.
  3. Sher G, Davey DA, Ogilvie M, Jacobs P. Pregnancy, Pre-eclampsia and Disseminated Intra vascular Coagulation. South African Medical Journal 1975; 49:1197.
  4. Sher G. The Diagnosis and Management of Accidental Hemorrhage with Associated Coagulopathy. South African Medical Journal 1975; 49:3183.
  5. Sher G. Intra-Amniotic Use of Urea and Prostaglandin F2 Alpha to Induce Labor in Pregnancies Complicated by Death of the Fetus.  South African Medical Journal 1976; 50:510.
  6. Cheifitz R, and Sher G. A Case Report of Meig’s Syndrome. South African Medical Journal 1976; 50:833.
  7. Sher G. Therapeutic Mid-Trimester Abortion by the Intrauterine Administration of Prostaglandins. South African Medical Journal 1976; 50:1173.
  8. Sher G, and Barnard P. The Alleviation of Uterocornual Spasm of the Fallopian Tubes during Hysterosalpingography by Intravenous Administration of Orciprenaline. South African Medical Journal 1976; 50:1164.
  9. Sher G, and Katz M. Inadequate Cervical Mucus – A Cause of “Idiopathic” Infertility. Fertility and Sterility 1976; 27:886.
  10. Sher G. Pathogenesis and Management of Uterine Inertia Complicating Abruptio Placentae with Consumption Coagulopathy.  American Journal of Obstetrics and Gynecology 1977; 129:164.
  11. Sher G. Letter to the Editor (Follow-up on “Inadequate Cervical Mucus”). Fertility and Sterility 1977; 28:117.
  12. Statland BE, Sher G, Freer DE, Kraybill EN, Yoder-Smith H, Hisley JC. Evaluation of a Modified Foam Stability (FS-50) Test: An Assay Performed on Amniotic Fluid to Predict Fetal Pulmonary Maturity. American Journal of Clinical Pathology 1978; 69:514.
  13. Sher G. Mid-trimester Intra-amniotic Administration of Prostaglandin F2Alpha in Combination with a Hyperosmolar Urea Solution – Effect upon Plasma Levels of Estradiol, Progesterone and Human Placental Lactogen (HPL). Acta Scand 1978; 57:223.
  14. Sher G, Statland BE, Freer DE, Kraybill EN. Assessing Fetal Lung Maturation by the Foam Stability Index Test. Obstetrics and Gynecology 1978; 52:673.
  15. Sher G. A Rational Basis for the Management of Abruptio Placentae.  Journal Repro Medicine 1978; 21:123.
  16. Sher G. Fistulas of the Lower Urinary Tract – Part I: Diagnosis and Etiology. The Female Patient 1978; 10:30.
  17. Sher G. Fistulas of the lower Urinary Tract – Part II: Management and Treatment. The Female Patient 1978; 11:95.
  18. Sher G, Statland BE, Freer DE, Hisley JC. Performance of the Amniotic Fluid Foam Stability – 50% (FS-50) Test: A Bedside Procedure for the Prenatal Detection of Hyaline Membrane Disease. American Journal of Obstetrics and Gynecology 1979; 134:705.
  19. Sher G. Preterm Labor – A Rational Basis for Management.  South African Journal of Hospital Medicine May 1979.
  20. Sher G. Congenital Incompetence of the Cervical Os – Reduction of Bulging Membranes with a Modified Foley Catheter.  Journal Repro Medicine 1979; 22:167.
  21. Freer DE, Statland BE, Sher G. Rational Basis Foam Stability Assays of Amniotic Fluid Surfactant. American Journal of Clinical Chemistry 1978; 24:1980.
  22. Sher G. Induction of Labor Following Intrauterine Death with Intra-Amniotic Hyperosmolar Urea and PG F2Alpha: Evaluation of Placental Endocrine Function and Changes in Coagulation Parameters; American Journal of Obstetrics and Gynecology 1979; 134:493.
  23. Freer DE, Statland BE, Sher G. Quantitation of Disaturated Phosphatidyl Choline and Phosphatidyl Glycerol in Amniotic Fluid by Fluorescence Diminution; Methodology and Clinical Results. American Journal of Clinical Chemistry 1979; 25:960.
  24. Sher G. Correction of Postpartum Uterine Inversion by the Application of Intra-vaginal Hydrostatic Pressure.  American Journal of Obstetrics and Gynecology 1979; 134:601.
  25. Sher G. Management of Hypertensive Disease in Pregnancy: A Pathophysiologic Approach: South African Journal of Hospital Medicine, September 1979.
  26. Sher G. Uterine Inertia and Abruptio Placentae: Proceedings of Ninth World Congress of OB/GYN – Tokyo, Japan 1979.
  27. Sher G, Berger GS. Glucocorticoids and Fetal Maturation: Background and Recommendations for Their Clinical Use in Obstetrics. Primatology/Neonatology 1980; 43:23.
  28. Sher G, Statland BE, Freer DE. Clinical Evaluation of the Quantitative Foam Stability Index (FSI) – Test. Obstetrics and Gynecology 1980; 55:617.
  29. Sher G. Management of Uterine Inertia Associated with Abruptio Placentae and Consumption Coagulopathy.  J of Reprod Med 1980; 25:115.
  30. Sher G. Abruptio Placentae and Consumption Coagulopathy.  Bayer Symposium on Obstetric Shock; Proceedings of International Symposium on Proteases and Anti-Proteases, Dubrovnik, Yugoslavia 1980.
  31. Sher G. Trasylol in the Management of Abruption Placentae with Consumption Coagulopathy and Uterine Inertia. J Reprod Med Sept 1980; 25(3):113-8.
  32. Sher G, Statland BE, Knutzen VK. Evaluation of Small Third-Trimester Fetus, Using the Foam Stability Index (FSI) – Test.  Obstetrics and Gynecology 1981; 58:314.
  33. Sher G. Management of Uterine Inertia Associated with Abruptio Placentae and Consumption Coagulopathy; Exerpta Medica – “Proceedings of the IXth World Congress of Obstetrics and Gynecology”, series No. 512, p. 372, 1981.
  34. Sher G. Aprotinin in the Management of Abruptio Placentae with Consumption Coagulopathy and Uterine Inertia; Proceedings of International Symposium on “Proteases-Anti Proteases on Clinical Practice” – Cavtat/Dubrovnik (published in English and German – 1981).
  35. Ito R, Statland BE, Sher G, Knutzen VK. Assaying Plasma Prekallikrein (PPK) by Chromogenic Based Method: Analytical Considerations and Reference Values in Healthy Adults, the Pregnant Woman, and the Neonate.  Proceedings of the International Kinin Symposium, Munich, Germany November 1981.
  36. Sher G, Statland BE, Knutzen, VK. Diagnostic Reliability of the Lecithin-Sphingomyelin (L/S) Ratio Assay, and the Quantitative Foam Stability (FSI) – Test: Results of a Comparative Study. J Reprod Med 1982; 27:51.
  37. Knutzen VK, Sher G. The Major Determinants of Perinatal Mortality in a Large Metropolitan Hospital Results of a Retrospective Study. J Reprod Med 1982; 27(7):395-400.
  38. Sher G. Health Care and the “Deserving Poor”. Hasting Cent Rep 1983; 13(1):9-12.
  39. Sher G, Statland BE. Evaluation of Lumadex TM-FSI Test for the Prenatal Assessment of Fetal Pulmonary Maturity. Obstetrics and Gynecology 1983; 61:4.
  40. Sher G, Statland BE, Knutzen VK. Identifying the Small-For-Gestational Age Fetus on the Basis of Enhanced Surfactant Production. Obstetrics and Gynecology 1983; 61:13.
  41. Sher G, Knutzen VK, Stratton CJ, Montakhab MM, Allenson SG. In Vitro Sperm Capacitation and Transcervical Insemination for the Treatment of Refractory Infertility. Fertility and Sterility 1984; 41:260.
  42. Sher G, Knutzen VK, Stratton CJ, Montakhab MM, Allenson SG, Mayville J, Rubenstein MA, Glass MJ, Bilach SM. The Development of a Successful Non-University Based Ambulatory In Vitro Fertilization/Embryo Transfer Program – Phase I. Fertility and Sterility 1984;41:511.
  43. Sher G, Statland BE. A Rational Basis for the Management of Abruptio Placentae with Consumption Coagulopathy. Clinical Obstetrics and Gynecology 1985; 28:1.
  44. Statland BE, Sher G. Reliability of Amniotic Fluid Surfactant Measurements.  American Journal of Clinical Pathology 1985; 83:382-384.
  45. Sher G. Controlled Ovarian Hyperstimulation (COH) in Preparation for In Vitro Fertilization and Embryo Transfer. “Foundations of In Vitro Fertilization: Drs. C.M. Freder, J.D. Paulson, A.H. DeCherney.”  Hemisphere Publishing, 1986.
  46. Sher G, Knutzen VK, Stratton CJ, Chotiner HC, Mayville J. In Vitro Fertilization and Embryo Transfer – Two Years Experience.  Journal of Obstetrics and Gynecology 1986; 67:309-315.
  47. Vaught LK, Stratton CJ, Julian P, Vaught WG, Sher G, Knutzen V, Marriage V. An Improved System for Catheter Loading During Embryo Transfer.  J In Vitro Fert Embryo Transf 1987 Dec;4(6):346-8.
  48. Behr BR, Sher G., Stratton CJ, Foote WD, Knutzen V. In Vitro Fertilization (IVF) of Mouse Ova in HEPES-buffered Culture Media.  Journal of In Vitro Fertilization and Embryo Transfer 1990; 7:9-15.
  49. Sher G, Herbert C, Jacobs M, Maassarani G. Assessment Of The Late Proliferative Phase Endometrium By Ultrasonography In Patients Undergoing In Vitro Fertilization And Embryo Transfer (IVF/ET).   Hum Reprod 1991; 6:232-237.
  50. Knutzen VK, Stratton CJ, McNamee P, Sher G, Huang TT, Soto-Albors C. Mock Embryo Transfer (MET) in Early Luteal Phase, the Cycles Prior to In Vitro Fertilization and Embryo Transfer.  Fertil and Steril 1992; 57:156-162.
  51. Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen V. Eliminating the Risk of Life-Endangering Complications Following Over-Stimulation with Menotropin Fertility Agents: A Study Performed On Women Undergoing In Vitro Fertilization and Embryo Transfer. Obstetrics and Gynecology 1993; 81:1009-1011.
  52. Sher G, Dodge S, Maassarani G, Knutzen V, Zouves C. Management of Suboptimal Sonographic Endometrial Patterns in Patients Undergoing In Vitro Fertilization and Embryo Transfer.  Hum Reprod 1993; 8:374-349.
  53. Feinman M, Sher G, Maassarani G, Vaught L, Andreyko J, Salem R, Zouves C. High Fecundity Rates in Donor Oocyte Recipients and In-Vitro Fertilization Surrogates Using Parenteral Oestradiol Valerate.  Hum Reprod 1993; 8:1145-1147.
  54. Feinman M, Sher G. Realizing the Potential of Assisted Reproductive Technologies through Third-Party Parenting.  Assisted Reproduction Reviews 1994; 4:2:74-79.
  55. Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P. High Fecundity Rates Following In Vitro Fertilization And Embryo Transfer (IVF/ET) In Antiphospholipid Antibody (APA) Seropositive Women Treated With Heparin And Aspirin.  Hum Reprod 1994; 9:2278-2283.
  56. Sher G, Feinman M, Zouves C, Maassarani G, Salem R. Autoimmunity In Implantation (Letter To The Editor), Hum Reprod 1995; 10:1272-1274.
  57. Sher G, Zouves C, Feinman M, Maassarani G. Prolonged Coasting: An Effective Method for Preventing Severe Ovarian Hyperstimulation Syndrome in Patients Undergoing In-Vitro Fertilization. Hum Reprod 1995; 10:3107-3109.
  58. Sher G, Feinman M. The Day-to-Day Realities: Commentary on the New Eugenics and Medicalized Reproduction. Cambridge Quarterly of Healthcare Ethics 1995; 4:313-315.
  59. Feinman M, Sher G, Earl H, Maassarani G. Auditing ART Success Rates: It Can Be Done. Journal of Assisted Reproduction and Genetics 1996; 13:1-4.
  60. Sher G. “Optimizing Implantation with IVF: Diagnostic and Therapeutic Considerations” Proceedings of American Society of Reproductive Medicine (ASRM) [Annual Meeting] , October 1996.
  61. Zouves C, Sher G, Sohn S, Feinman M, Maassarani G. Prediction and Prevention of Severe Ovarian Hyperstimulation Syndrome, Proceedings of Xth World Congress on In Vitro Fertilization and Assisted Reproduction. Vancouver, Canada May 1997.
  62. Barnes F, Zouves C, Rodriguez H, Sher G, Andreyko J, Gililland J. Clinical Experience with In Vitro Maturation of Human Oocytes, Proceedings of Xth World Congress on In Vitro Fertilization and Assisted Reproduction. Vancouver, Canada May 1997; Publisher – Monduzzi Editore 1997.
  63. Zouves C., Sher G, Sohn S, Barnes F, Maassarani G, Feinman M. Prediction and Prevention of Ovarian Hyperstimulation Syndrome (OHSS), Proceedings of Xth World Congress on In Vitro Fertilization and Assisted Reproduction. Vancouver, Canada May 1997; Publisher – Monduzzi Editore 1997.
  64. Sher G, Feinman M. Accountability, Representation and Advertising in Reproductive Medicine. Jacobs Institute of Women’s Health Issues, May 1997.
  65. Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Ching W. The Selective use of Heparin/Aspirin Therapy, Alone or in Combination with Intraveneous Immunoglobulin G in the Management of Antiphospholipid Antibody Positive Women Undergoing In Vitro Fertilization. Am J Repr Immunol 1998; 40(2):74-82.
  66. Sher G, Maassarani G, Zouves C, Feinman M, Sohn S, Matzner W, Chong P, Ching W. The use of Combined Heparin/Aspirin and Immunoglobulin G. Therapy in the Treatment of IVF Patients with Antithyroid Antibodies. Am J Repr Immunol, 1998; 39:223-5.
  67. Sher G., Zouves, C., Maassarani G., Matzner W., Chong P., Ching W. A Rational Basis for the Use of Combined Heparin/Aspirin and IVIg Immunotherapy in the Treatment of Recurrent IVF Failure Associated with Antiphospholipid Antibodies. Am Jrnl Repr Immunol 1998;39:391-4.
  68. Sher G, Fisch JD. Better Access to Infertility Treatment. (Editorial) The Las Vegas Review Journal.  September 27, 1999.
  69. Fisch JD, Sher G. The Preantral Follicle Number on CD1 Correlates with the number of MI Oocytes. Fertility and Sterility 2000; 74:S96.
  70. Fisch JD, Sher G. Sclerotherapy: A Less Invasive Alternative for the Treatment of Ovarian Endometriomas Prior to IVF. Fertility and Sterility 2000; 74:S202.
  71. Rodriguez H, Ross R, Fisch JD, Sher G. A Graduated Embryo Scoring (GES) System Predicts Blastocyst Development From Cleavage-Stage Embryos. Fertility and Sterility 2000; 74:S255.
  72. Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Ching W. The Selective use of Heparin/Aspirin Therapy Alone or in Combination with Intravenous Immunoglobulin G, in the Management of Antiphospholipid Positive Women Undergoing In Vitro Fertilization.  Am J Reprod Immunol 1998; 40(2):74-82.
  73. Sher G, Fisch JD, Maassarani G, Matzner W, Ching W, Chong P. Antibodies to Phosphatidylethanolamine and Phosphatidylserine are Associated with Increased Natural Killer Cell Activity in Non-Male Factor Infertility Patients. Hum Reprod 2000; 15(9):1932.
  74. Sher G, Fisch JD. Sildenafil (Viagra) Improves Uterine Artery Blood Flow in ART Patients with Prior Failed Cycles and Poor Endometrial Response.  Hum Reprod 2000; 15(4):806-9.
  75. Sher G, Clark DA, Fisch JD, Coulam CB, Matzner W. A Rational Basis for Antiphospholipid Antibody Testing and Selective Immunotherapy in Assisted Reproduction: A Rebuttal to the American Society of Reproductive Medicine Practice Committee Opinion. Fertility and Sterility 2000;74(4):631-4
  76. Sher G, Matzner W, Chong P, Ching W. The generalizability of antiphospholipid testing.  Fertility and Sterility – September 2000 (Vol. 74, Issue 3, Pages 611-612).
  77. Fisch JD, Rodriguez H, Ross R, Overby G, Sher G. The Graduated Score (GES) Predicts Blastocyst Formation and Pregnancy Rate from Cleavage-Stage Embryos. Hum Reprod. 2001; 16(9):1970-1975.
  78. Sher G, Fisch JD. A Good Study Design Cannot Improve Flawed Data.  (Letter to the Editor).  Fertility and Sterility 2001; 76:636-7.
  79. Sher G, Fisch JD. “In silico experiments” – yes, but the great western cowboy “random chance” is still alive.  Fertility and Sterility – September 2001.
  80. Fisch JD, Sher G, Uzelac P. Avoiding Triplet Pregnancies in Assisted Reproduction.  In Triplet Pregnancy by Keith LG, Blickstein I, Oleszczuk J (Ed) Parthenon Publishing, London.
  81. Fisch JD, Sher G, Rodriguez H, Overby G, Adamowicz M, Keskintepe L. Graduated embryo score (GES) is superior to day-3 morphologic criteria alone for predicting ART outcome.  Fertility and Sterility – September 2002 (Vol. 78, Issue Supplement 1, Page S 136).
  82. Fisch JD, Sher G, Maassarani G, Danner L. Intravenous immunoglobulin G (IVIG) is associated with markedly improved IVF outcome in patients with elevated peripheral natural killer cell activity (NKA+) and prior unexplained IVF failure.  Fertility and Sterility – September 2002 (Vol 78, Issue Supplement 1, Page S111)
  83. Sher G, Fisch JD. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility and Sterility November 2002; 78(5):1073-6.
  84. Fisch JD, Sher G. Colpohydrosonography (CHS): A Novel Method for Optimizing the Precision of Embryo Placement. J. Reprod Med. 2003; 8:325-9.
  85. Sher G, Fisch JD. Measuring uterine depth with colpohydrosonography.  J Reprod Med – May 2003 (Vol. 48, Issue 5, Pages 325-9)
  86. Sher G, Fisch JD. Multiple confounders-measured with error (Letter to the Editor). Fertility and Sterility 2003; 79:1257.
  87. Fisch JD, Sher G, Keskintepe L. A randomized, controlled trial of low dose GnRH antagonist started on day-2 in “poor responders” undergoing stimulation with luteal phase GNRH agonist, estrogen priming and high-dose FSH.  Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Page 108).
  88. Ahlering P, Keskintepe L, Sher G, Fisch JD, Danner L, Maassarani G. The sperm DNA integrity assay (SDI™) a valuable method for assessing sperm vitality in preparation for In Vitro Fertilization (IVF).  Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Page 113).
  89. Adamowicz M, Keskintepe L, Zody R, Danner L, Fisch JD, Sher G. Timing of blastocyst transfer relative to the thaw: a critical factor in outcome following FET.  Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Page 151).
  90. Brusil I, Keskintepe L, Adamowicz M, Zody R, Fisch JD, Sher G. Predictive value of the differential in nucleolar count (ND) between the pronuclei of 16-18 hour zygote and embryo quality on day-3 and 5.  Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Pages 159-160).
  91. Fisch JD, Sher G, Adamowicz, Zody R, Keskintepe L. The Gratuated Embryo Score (GES) on day-3 of culture predicts outcome from blastocyst transfer.  Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Pages 165-166)
  92. Coulam CB, Ahlering P, Rodriguez H, Keskintepe L, Sher G, Roussey R. Pregnancy outcome after IVF/ET among couples who have elevated DNA fragmentation determined by the sperm DNA integrity assay (SDIa™). Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Page 207)
  93. Fisch JD, Sher G. Sclerotherapy, a simple alternative to surgery for the treatment of ovarian endometriotic cysts in women scheduled to undergo IVF.  Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Pages 225-226).
  94. Keskintepe L, Machnicka A, Pacholczyk G, Norris K, Brackett BG, Sher G. High incidence of tetraploid male bovine blastocyst development from oocytes injected with sexed freeze-dried spermatozoa.  Fertility and Sterility – September 2003 (Vol. 80, Issue Supplement 3, Page 261).
  95. Fisch JD, Sher G, Adamowicz A, Keskintepe L. The graduated embryo score (GES) predicts ART outcome better than a single day 3 evaluation and achieves results associated with blastocyst transfer from day-3 ET. Fertility and Sterility December 2003 80(6): 1352-1358.
  96. Sher G, Keskintepe L, Nouriani M, Roussev R, Batzofin J.  Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of ’embryo competency’ and IVF outcome. Reproductive BioMedicine Online 2004 Vol. 9, No. 1. 74-78.
  97. Fisch JD, Sher G. Sclerotherapy with 5% tetracycline is a simple alternative to potentially complex surgical treatment of ovarian endometriomas before in vitro fertilization. Fertility and Sterility 2004; 437-441.
  98. Sher G, Keskintepe L, Fisch JD, Acacio BA, Ahlering P, Batzofin J, Ginsburg M. Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer.  Fertility Sterility – May 2005 (Vol. 83, Issue 5, Pages 1410-3).
  99. Sher G, Keskintepe L, Fisch JD, Acacio BA, Ahlering P, Batzofin J. Influence of early ICSI-derived embryo sHLA-G expression on pregnancy and implantation rates: a prospective study.  Human Reproduction. (Vol. 20, Issue 5, Pages 1359-1363).
  100. Sher G, Keskintepe L, Ginsburg M. SHLA-G expression: is it really worth measuring?     RBM Online 2007.
  101. Fish JD, Keskintepe L, Ginsburg M, Adamowicz M, Sher G. Graduated Embryo Score     and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer. In press, Fertility and Sterility, 2007.
  102. Fisch JD, Keskintepe L, Sher G. Gonadotropin releasing hormone agonist/antagonist conversion with estrogen priming: a novel approach for improving ART outcomes in poor-responders. Submitted to Fertility and Sterility 2007.
  103. Sher G, Keskintepe L, Ginsburg M. SHLA-G expression: Is it really worth measuring? RBM online 2007.  14 (1) 9-10.
  104. Fisch JD, Keskintepe L, Ginsburg M, Adamowicz M, Sher G (2007). Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single –embryo transfer.  In Press, Fertility and Sterility.
  105. Sher G, Keskintepe L, Keskintepe M, Ginsburg M, Maassarani G, Yakut T, Baltaci V, Kotze D, Unsal E. Oocyte Karyotyping by Comparative Genomic Hybridization Provides a Highly Reliable Method for Selecting “Competent” Embryos, Fertility and Sterility.  In Press, Fertility and Sterility.
  106. Fisch JD, Keskintepe L, Sher G (2007). Gonadotropin releasing hormone agonist/antagonist conversion with estrogen priming: a novel approach for improving ART outcomes in poor responders. In Press, Fertility and Sterility.
  107. Sher G, Fisch JD, Keskintepe L (2007). Vaginal Sildenafil treatment for persistently thin endometrium during ART: an eight year experience.  Submitted to RBM Online.
  108. Keskintepe L, Sher G, Keskintepe M (2007). Reproductive oocyte/embryo karyotyping: a comparison between fluorescence in situ hybridization (FISH) versus comparative genomic hybridization (CGH). Submitted to RMB online.
  109. Fisch JD, Keskintepe L, Sher G, (2007). Gonadotropin releasing hormone agonist/antagonist conversion with estrogen priming: a novel approach for improving ART outcomes in poor-responders. Fertility and Sterility. 89 (2): 342-347.
  110. Sher G, Keskintepe L, Mukaida T, Keskintepe M, Ginsburg M, Agca Y, Maassarani G, Bayrak A (2008). Selective Vitrification of Euploid Oocytes Markedly Improves Survival, Fertilization and Pregnancy-generating Potential. Reprod Biomed Online. 2008 Oct; 17(4):524-9.
  111. Keskintepe L, Sher G, Adamowicz M, Machnicka A, Tortoriello D, Bayrak A, Zody A (2008). Vitrification improves Post-Cryotransfer Outcome of Blastocysts biopsied on day 3: a comparative study. Submitted to Fertility and Sterility.
  112. Sher G, Keskintepe L, Keskintepe M, Ginsburg M, Brody S, Maassarani G, Tortoriello D (2008). Selective Vitrification followed by deferred Cryotransfer of CGH-normal embryos markedly improves IVF outcome. Submitted to New England Journal of Medicine.
  113. Keskintepe L, Agca Y, Sher G, Keskintepe M, Maassarani G (2009). High survival rate of metaphase II human oocytes after first polar body biopsy and vitrification: determining the effect of previtrification conditions.  Fertility and Sterility 92 (5), 1706-1715.
  114. Sher G, Keskintepe L, Keskintepe M, Maassarani G, Tortoriello D, Brody S (2009). Genetic analysis of human embryos by metaphase comparative genomic hybridization (mCGH) improves efficiency of IVF by increasing embryo implantation rate and reducing multiple pregnancies and spontaneous miscarriages.  Fertility and Sterility. 92 (6), 1886-1894.
  115. Keskintepe L, Sher G, Machnicka A, Tortoriello D, Bayrak A, Fisch J, Agca Y (2009). Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing. Journal of Assisted Reproduction and Genetics. DOI 10.1007/s10815-009-9369-8.
  116. Kotze DJ, Hansen P, Keskintepe L, Snowden E, Sher G, Kruger T.(2010) Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing. J Assist Reprod (6):309-16
  117. Kotze DJ, Hansen P, Keskintepe L, Snowden E, Sher G, Kruger T. Embryo selection criteria based on morphology VERSUS the expression of a biochemical marker (sHLA-G) and a graduated embryo score: prediction of pregnancy outcome. J Assist Reprod Genet. 2010 Jun; 27(6):309-16.
  118. Kotze D, Keskintepe L, Sher G, Kruger T, Lombard C. A linear karyotypic association between PB-I, PB-II and blastomere using sequentially performed comparative genome hybridization with no association established between karyotype, morphologic, biochemical (sHLA-G expression) characteristics, blastocyst formation and subsequent pregnancy outcome. Gynecol Obstet Invest; 2012; 74(4):304-12.
  119. Yakut T, Karkucak M, Sher G, Keskintepe L. Comparison of aneuploidy frequencies between in vitro matured and unstimulated cycles oocytes by metaphase comparative genomic hybridization (mCGH). Mol Biol Rep. 2012 May; 39(5):6187-91
  120. Kotze D, Kruger TF, Lombard C, Padayachee T, Keskintepe L, Sher G. The effect of the biochemical marker soluble human leukocyte antigen G on pregnancy outcome in assisted reproductive technology–a multicenter study. Fertil Steril. 2013; 100(5):1303-9.

ABSTRACTS

  1. Sher G, Katz M. Inadequate Cervical Mucus – A Cause of “Idiopathic” Infertility. 18th South African Congress of Obstetrics and Gynecology, 1976 (abstract).
  2. Sher G. Therapeutic Mid-Trimester Abortion by the Intrauterine Administration of Prostaglandins. 18th South African Congress of Obstetrics and Gynecology 1976 (abstract).
  3. Sher G. Accidental Hemorrhage with Severe Coagulopathy – Maternal Prognosis.  18th South African Congress of Obstetrics and Gynecology, 1976 (abstract).
  4. Sher G. Intra-amniotic Use of Urea and Prostaglandin F2 Alpha to Induce Labor in Pregnancies Complicated by Death of the Fetus. 18th South African Congress of Obstetrics and Gynecology, 1976 (abstract).
  5. Freer DE, Statland BE, Sher G. Volume Fraction in the FFSI. 10th Congr. Clin Chem, 1978).
  6. Freer DE, Statland BE, Sher G. Clinical Evaluation of Modified Amniotic Fluid Foam Stability Test for the determina­tion of Fetal Pulmonary Maturity. Tenth Internati­onal Congress of Clinical Chemistry, Mexico 1978 (abstract).
  7. Sher G., Statland BE, Freer DE, Kraybill, EN, Hisley J. The Foam Stability Index (FSI) – Test.     Society for Gynecologic Investigation Annual Meeting, Atlanta, Georgia 1978                  (abstract).
  8. Sher G, Statland BE, Freer DE, Kraybill EN, Hisley J. Evaluation of a Sensitive and Rapid Test for Functional Surfactant Activity (The FS-50 Test).  ACOG Annual Clinical Meeting, Anaheim, California 1978 (abstract).
  9. Statland BE, Sher G, Freer DE. The Evolution of a Simple, Reliable, Quantitative Foam Stability Assay of Amniotic Fluid Surfactant.  4th International Colloquium of Prospective Biology, France 1978 (abstract).
  10. Sher G. Abruptio Placentae and Consumption Coagulopathy.  International Symposium on Kinins, Japan 1978 (abstract).
  11. Sher G. Abruptio Placentae with Consumption Coagulopathy and Uterine Inertia: Therapeutic Effect of Parenteral Infusion of Trasylol on Uterine Contractility.  Shock Symposium, Tokyo and Osaka, Japan 1978 (abstract).
  12. Sher G. Evaluation of a New Assay, the Foam Stability Index (FSI) – Test, for the Prenatal Assessment of Fetal Pulmonary Maturity.  ACOG National Meeting, New York April 1979 (abstract).
  13. Sher G. Evaluation of the Foam Stability Index (FSI) – Test.  Ninth World Congress of the International Federation of Obstetricians and Gynecologists (FIGO), Japan 1979 (abstract).
  14. Sher G. Management of Uterine Inertia Associated with Abruptio Placentae and Consumption Coagulopathy.  Ninth World Congress of the International Federation of Obstetricians and Gynecologists (FIGO), Japan 1979 (abstract).
  15. Sher G. Management of D.I.C. Associated with Abruptio Placentae.  Symposium on Shock in Obstetrics, Royal Hotel and Osaka Japan 1979 (abstract).
  16. Sher G. Management of Uterine Inertia Associated with Abruptio Placentae and Consumption Coagulopathy.  International Symposium, “Proteases and Anti-Proteases in Clinical Practice,” Cavtat/Dubrovnik, Yugoslavia, May 1980 (abstract).
  17. Sher G. Use of FSI – Test in Discriminating Between the Severely Growth-Retarded Fetus, and the Appropriately Grown, but Very Small, Preterm Fetus.  Annual Meeting of the Society of Perinatal Obstetricians, San Antonio, Texas, January 1981 (abstract).
  18. Sher G. A Rational Approach to the Management of the High-Risk, Small Third-Trimester Fetus.  Annual Meeting of the Society of Perinatal Obstetricians, San Antonio, Texas, 1982 (abstract).
  19. Sher G, Knutzen VK, Statland BE. A Central Role for Amniocentesis and the Foam Stability Index (FSI) – Test in the Management of the High-Risk, Small Third-Trimester Fetus (STF): A Prospective Study.  Society of Perinatal Obstetricians Annual Meeting, San Antonio, Texas, February 1982 (abstract).
  20. Sher G, Statland BE, Knutzen VK. The Diagnostic Value of Quantitative Amniotic Fluid Foam Stability Index (FSI) – Test for Prenatal Fetal Assessment. Annual Meeting of the Society of Perinatal Obstetricians, San Antonio, Texas, February 1982 (abstract).
  21. Boris M, Statland BE, Miller B, Sher G. Performance Evaluation of the Beckman FSI Cassette. American Association of Clinical Chemists Annual Meeting, Los Angeles, California, 1982 (abstract).
  22. Sher G, Statland BE, Knutzen VK. Clinical Evaluation of the Quantitative Amniotic Fluid Foam Stability Index (FSI) – Test for Prenatal Assessment.  American College of Pediatrics, District VIII Meeting, Neonatology, Jackson, Wyoming, May 1982, (abstract).
  23. Sher G, Knutzen VK, Statland BE. An Important Role for the Quantitative Amniotic Fluid Foam Stability Index (FSI) – Test in the Management of the High-Risk Small Third-Trimester Fetus (STF): A Prospective Study.  American College of Pediatrics, District VIII Meeting, Neonatology, Jackson, Wyoming, May 1982 (abstract).
  24. Sher G, Statland BE, Painter PC. Methods of Evaluating Fetal Lung Maturity.  34th National Meeting, American Association of Clinical Chemists, Anaheim, California August 1982, (abstract).
  25. Sher G, Statland BE, Knutzen VK. Concurrent Measurements of Fetal Biparietal Diameter (BPD) and Amniotic Fluid Foam Stability Index (FSI). Tenth World Congress of Gynecology and Obstetrics (FIGO), San Francisco, October 1982 (abstract).
  26. Sher G, Statland BE, Knutzen VK. Clinical Evaluation of Amniotic Fluid Foam Stability Index (FSI) – Test.  Tenth World Congress of Gynecology and Obstetrics (FIGO), October, 1982, San Francisco,
  27. Sher G, Statland BE, Knutzen VK. The Kallikrein-kinin System of Normal Pregnancy. Tenth World Congress of Gynecology and Obstetrics (FIGO), October 1982, San Francisco (abstract).
  28. Sher G, Statland BE. Management of High-Risk Small Third-Trimester Fetus – Recent Advances in the U.S.A..  30th Annual Meeting of Northern Japan Society of Obstetrics and Gynecology, September 1982, Akita, Japan (abstract).
  29. Sher G, Statland BE, Knutzen VK, Ito R. The Kallikrein kinin System of Normal Pregnancy; Tenth World Congress of Gynecology and Obstetrics, San Francisco, California; held under the auspices of the International Federation of Gynecology and Obstetrics, October 17-22, 1982 (abstract).
  30. Sher G, Statland BE, Knutzen VK. Concurrent Measurements of Fetal Biparietal Diameter and Amniotic Fluid Foam Stability Index Test.  Tenth World Congress of Gynecology and Obstetrics, San Francisco, California; held under the auspices of the International Federation of Gynecology and Obstetrics, October 17-22, 1982 (abstract).
  31. Sher G, Statland BE, Knutzen VK. Clinical Evaluation of Amniotic Fluid Foam Stability Index Test. Tenth World Congress of Gynecology and Obstetrics, San Francisco, California; held under the auspices of the International Federation of Gynecology and Obstetrics, October 17-22, 1982 (abstract).
  32. Stratton CJ, Montakhab MM, Sher G. Extracorporeal Human Sperm Capacitation: Ultrastructural Analysis; Anatomical Records, Vol. 1, P. 175A, Annual American Association of Anatomists, Seattle, Washington, April 11, 1984 (abstract).
  33. Sher G, Knutzen VK, Stratton CJ, Montakhab MM. Successful Management of Refractory Infertility through Transcervical Insemination of Human Spermatozoa Capacitated In Vitro.  Proceedings of Third World Congress of InVitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984 (abstract).
  34. Stratton CJ, Montakhab MM, Sher G, Knutzen VK. Extracorporeal Human Sperm Capacitation: Ultra-structural Analysis.  Proceedings of Third World Congress of InVitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984 (abstract).
  35. Montakhab MM, Stratton CJ, Sher G, Knutzen VK. A Possible Role for the Coronal Radiata in Promoting In Vitro Fertilization of Human Pre-ovulatory Oocytes. Proceedings of Third World Congress of InVitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984 (abstract).
  36. Sher G, Knutzen VK, Stratton CJ, Montakhab MM. Comparative Evaluation of Progesterone Therapy and HCG Administration for the Enhancement of Corpus Luteum Function. Proceedings of Third World Congress of InVitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984 (abstract).
  37. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. Possible Factors Contributing to a High Success Rate with In Vitro Fertilization and Embryo Transfer.  Proceedings of Third World Congress of InVitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984 (abstract).
  38. Sher G, Knutzen VK, Stratton CJ, Chotiner HC.  Successful In Vitro Fertilization/Embryo Transfer InAssociation with a Private (Non-University Based) Practice.  Proceedings of Third World Congress of InVitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984 (abstract).
  39. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. In Vitro Sperm Capacitation and Transcervical Intrauterine Insemination for the Management of Refractory Non-Organic Infertility.  Proceedings of the Annual Meeting of the American Society of Gynecologic Laparoscopists, Las Vegas, Nevada, and November 1984 (abstract).
  40. Sher G, Knutzen VK, Stratton CJ, Chotiner H.C. Augmentation of Corpus Luteum Insufficiency Following In Vitro Fertilization and Embryo Transfer with Parenteral Human Chorionic Gonadotropin.  Proceedings of the Annual Meeting of the American Society of Gynecologic Laparoscopists, Las Vegas, Nevada, and November 1984 (abstract).
  1. Sher G, Knutzen VK, Stratton CJ, Chotiner H.C. Endocervical Embryo Sequestration – A Possible Cause of Failure Following In Vitro Fertilization and Embryo Transfer.  Proceedings of the Annual Meeting of the American Society of Gynecologic Laparoscopists, Las Vegas, Nevada, and November 1984 (abstract).
  2. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. Management of Non-Organic Female Infertility by Transcervical Insemination of Sperm Capacitated In Vitro.  Proceedings of the Combined Royal Fertility Society and Canadian Fertility Society Meeting, September 1984, Vancouver, Canada – Published in the Journal of Obstetrics and Gynecology, January 1985, (Abstract).
  3. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. Factors Contributing Toward the Successful Establishment of an IVF/ET Program in Private Practice in the U.S.A. Proceedings of the Combined Royal Fertility and Canadian Fertility Society Meeting, September 1984, Vancouver, Canada – Published in the Journal of Obstetrics and Gynecology, January 1985 (abstract).
  4. Sher G. Evaluation of Three Procedures Employed by the Northern Nevada Fertility Center Laboratory, Which Differ From Other Clinics.  Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985 (abstract).
  5. Sher G. Knutzen VK, Stratton C. Ultrasound Assessment of Follicle Dimensions – of Doubtful Value in Patients receiving Human Menopausal Gonadotropin alone in preparation for In Vitro Fertilization and Embryo Transfer.  Published in the abstracts of the 5th World Congress of InVitro Fertilization and Embryo Transfer, April 1987, Norfolk, Virginia (abstract).
  6. Sher G, Knutzen VK, Stratton C. Three Years Experience Using In Vitro Sperm Capacitation with Transcervical Intrauterine Insemination for the Treatment of Refractory Infertility. Published in the Abstracts of the 5th World Congress of InVitro Fertilization and Embryo Transfer, April, 1987, Norfolk, Virginia, (abstract).
  7. Sher G, Vaught WG, Julian PV, Vaught LK. The Interrelationship between Plasma Estradiol Concentrations Before and After Oocyte Retrieval and Pregnancy Rate with In Vitro Fertilization/Embryo Transfer.  Published in the Abstracts of the 5th World Congress of In Vitro Fertilization and Embryo Transfer, April, 1987 Norfolk, Virginia (abstract).
  8. Sher G, Knutzen VK, Stratton C. The Value and Methods of Measurement that Improve Outcome in Our In Vitro Fertilization Program.  Published in the Abstracts of the 5th World Congress of In Vitro Fertilization and Embryo Transfer, April, 1987 Norfolk, Virginia (abstract).
  9. Knutzen VK, Sher G, Mayville WJ. Role of Psychological Screening Inventory (PSI) in Assessing and Managing the In Vitro Fertilization (IVF) Couple.  Published in the Abstracts of the 5th World Congress of InVitro Fertilization and Embryo Transfer, April, 1987, Norfolk, Virginia (abstract).
  10. Sher G, Knutzen VK, Stratton C. Possible Factors Contributing Towards the Success of In Vitro Fertilization and Embryo Transfer.  Published in the Abstracts of the 5th World Congress of In Vitro Fertilization and Embryo Transfer, April, 1987, Norfolk, Virginia, (Abstract).
  11. Sher G, Behr BR, Stratton CJ, Foote WD, Vaught LK, Knutzen VK. Initiation of early cleavage and increased overall cleavage rate of mouse embryos using IVF.  Fertility and Sterility.  43rd Annual Meeting of the American Fertility Society, 1987, (Abstract).
  12. Sher G, Jacobs MH, Vaught LK, Vaught WG, Knutzen VK, Soto-Albors C. Intrauterine Insemination (IUI) Versus IUI WithTransperitoneal Insemination (TPI) in Patients with Unexplained Infertility:  Comparing Clomiphene Versus Human Menopausal Gonadotropin (hMG) – induced Controlled Ovarian Hyperstimulation (COH).  6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April, 1989 (Abstract).
  13. Sher G, Stratton CJ, Knutzen LA, Montakhab MM, Soto-Albors CE. The Introduction of 27 g Needle Removal (Peeling) of the Sperm-hardened Coronal Cells from the Human Embryo.  VIth World Congress InVitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, 1989, (Abstract).
  14. Sher G, Vaught WG, Vaught LK, Knutzen VK. The Comparative Effect of hCG Versus Progesterone Administration in the Luteal Phase or Corpus Luteum Function as Judged by Luteal Phase Plasma Progesterone and Estradiol Concentrations and the Length of the Luteal Phase.  6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April, 1989 (Abstract).
  15. Sher G, Vaught WG, Vaught LK, Knutzen VK. The Influence of Age, Uterine Length, `Pre-Post Egg Retrieval Plasma Estradiol Drop, and the Number of Cleaved Embryos Transferred to the Uterus – on Outcome Following IVF/ET. 6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April, 1989, (Abstract).
  16. Knutzen LA, Stratton CJ, Knutzen VK, Sher G, Behr B, Julian P, Vaught LK, Vaught WG, Melarkey D. Evaluation of Lumen Parameters of Various Catheters Contacting Human Ovas and Embryos.  6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, April, 1989 (Abstract).
  17. Sher G, Knutzen VK, Soto-Albors CE, Fuller D, Shyrock K, Stratton CJ, Behr B, McNamee P. Mock Embryo Transfer (MET) in Early Luteal Phase, the Cycle Prior to In Vitro Fertilization and Embryo Transfer (IVF/ET): A Preliminary Report. 6th World Congress InVitro Fertilization and Alternate Assisted Reproduction, Jerusalem, Israel, 1989, (Abstract).
  18. Sher G, Knutzen VK. Assessment of variables that impact on success rate following IVF/ET. 6th World Congress of In Vitro Fertilization and Embryo Transfer, April 1989, Jerusalem, Israel, (Abstract).
  19. Sher G, Knutzen VK. Intrauterine insemination with transperitoneal insemination, an analysis of outcome comparing various methods of controlled ovarian hyperstimulation.  6th World Congress of In Vitro Fertilization and Embryo Transfer, April 1989, Jerusalem, Israel, (Abstract).
  20. Sher G, Cohen N, Knutzen VK. Enhanced Sonographic Imaging, Applied in the Management of Assisted Reproduction.  American Society of Gynecologic Laparoscopists, 4th World Congress on Transvaginal Sonography, June 1991, Chicago, Illinois (Abstract).
  21. Vaught L, Vaught W, Huen N, Quinones R, Sher G, Maassarani G. Comparison of the In Vitro Fertilization Rate of Sperm Prepared by Multiple-Tube Swim-up and Sperm Select Columns.  7th World Congress of In Vitro Fertilization and Embryo Transfer, Paris, France, July 1991 (Abstract).
  22. Vaught L, Vaught W, Huen N. Quinones R, Sher G, Maassarani G. Effect on Incubation of Sperm in Test Yolk Buffer on Fertilization Rate in an IVF Program.  7th World Congress of In Vitro Fertilization and Embryo Transfer, Paris, France, July 1991 (Abstract).
  23. Vaught L, Vaught W, Huen N, Quinones R, Sher G, Maassarani G. Fertilization of Human Oocytes after Cumulus Oophorus Removal by Hyaluronidase.  7th World Congress of In Vitro Fertilization and Embryo Transfer, Paris, France, July 1991 (Abstract).
  24. Brothers AJ, Stratton CJ, Knutzen VK, Sher G, Allenson S. Progesterone levels 48 hours prior to oocyte retrieval serve to predict successful implantation.  7th World Congress on In Vitro Fertilization and Assisted Procreation, July 1991, Paris, France (Abstract).
  25. Sher G. Ultrasound Status of the Endometrium, Relationship to Stimulation and Pregnancy following In Vitro Fertilization and Embryo Transfer (IVF/ET).  4th Annual InVitro Fertilization and Embryo Transfer, Santa Barbara, California, July 1991 (Abstract).
  26. Sher G, Cohen N, Knutzen VK. Next Generation Ultrasound.  World Congress of Gynecologic Endoscopy AAGL 20th Annual Meeting, Las Vegas, Nevada, November 1991 (Abstract).
  27. Sher G, Knutzen V. Suboptimal Endometrial Patterns on Transvaginal Ultrasound Scanning.  5th Annual InVitro Fertilization and Embryo Transfer, Santa Barbara, California, July 1992 (Abstract).
  28. Sher G, Knutzen V. Comparing Methods of Controlled Ovarian Hyperstimulation (COH) with Outcome in Women Undergoing Intrauterine Insemination (IUI) and Transperitoneal Insemination (IUI).  5th Annual InVitro Fertilization and Embryo Transfer, Santa Barbara, California, July 1992 (Abstract).
  29. Sher G. A New Approach to the Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) which eliminates the Need for Cancellation of the Treatment Cycle.  The International Congress of Gynecologic Endoscopy, AAGL 21st Annual Meeting, Chicago, Illinois, September 1992 (Abstract)
  30. Sher G, Cohen N, Knutzen V. Next Generation Ultrasound (NGU).  The International Congress of Gynecologic Endoscopy AAGL 21st Annual Meeting, Chicago, Illinois, September 1992 (Abstract-Video).
  31. Stratton CJ, Brothers AJ, Knutzen VK, Julian P, Branch M, Behr B, Knutzen LA, Sher G. Effect of Sperm-Bound Anti-Sperm Antibody Presence on Embryo Quality and Pregnancy Rate. The American Fertility Society, 48th Annual Meeting, New Orleans, Louisiana, October 31 – November 5, 1992 (Abstract).
  32. Sher G, Salem R. Eliminating Complications associated with Severe Ovarian Hyperstimulation (OHSS) in Patients Receiving Menotropins for IVF/ET.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  33. Sher G, Feinman M. High Fecundity Rates in Donor Oocyte Recipients and In Vitro Fertilization Surrogates using Parenteral Estradiol Valerate.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  34. Sher G, Knutzen V, Zouves C. Suboptimal Sonographic Late Proliferative phase Endometrial Patterns in Patients Undergoing IVF.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  35. Vaught L, Vaught W, Tomasin J, Sher G.  Effect of Preincubation of Sperm in Test Yolk Buffer Stored at 22 C or 4 C on Fertilization Rate of Human Oocytes.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  36. Vaught L, Dodge S, Vaught W, Sher G. Effect of Interval between hCG administration and oocyte retrieval on oocyte maturity, fertilization rate and pregnancy in leuprolide acetate-suppressed IVF cycles.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  37. Vaught L, Vaught W, Sher, G. Human embryo Culture in HAM’s F-10 without Hypoxanthine and with Reduced Glutathione.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  38. Brothers AJ, Sher G, Knutzen VK Sustained cultures of Human Granulosa Cells for the Assessment of Exogenous Gonadotropin Biopotency.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  39. Brothers AJ, Sher G, Knutzen VK, Christenson J, Andrews BT. Long-term human pituitary cell cultures with retrained functional expression.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993 (Abstract).
  40. Sher G. Ethical and Moral Considerations associated with Pre-implantation Genetic Diagnosis.  Choice, Control and Responsibility in Genetic Manipulation: Designs on Life.  4th Annual Congress of Healthcare Ethics and Ethics Committees, University of California, Berkeley.  April, 1994 (Abstract).
  41. Sher G. Improving IVF outcome through the treatment of antiphospholipid antibody (APA) seropositive women with Heparin and Aspirin.  IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995 (Abstract).
  42. Sher G, Zouves C. A new approach to the management of severe ovarian hyperstimulation (OH) which eliminates the need for cancellation of the treatment cycle.  IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995, (Abstract).
  43. Sher G. The Role of intrauterine insemination in the treatment of infertility: An analysis of 1602 cycles. IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995 (Abstract).
  44. Sher G, Feinman M, Zouves C, Maassarani G.  Controlled ovarian hyperstimulation in normally ovulating women does not result in multiple ovulations.  IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995 (Abstract).
  45. Brothers AJ, Sher G. Sustained cultures of human granulosa cells for the assessment of exogenous gonadotropin biopotency.  IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995 (Abstract).
  46. Brothers AJ, Sher G, Zouves C, Willman S, Kuttner G, Ulehlova E, Waterhouse K, Huen N. PROD:  A gentle enzymatic method for assisted hatching to enhance implantation.  IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995 (Abstract).
  47. Brothers AJ, Sher G, Christenson J, Andrews BT. Long Term human pituitary cell cultures with retained functional expression.  IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995 (Abstract)
  48. Feinman M, Sher G, Salem R, Andreyko J.  Auditing IVF success rates: It can be done IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3 – 7, 1995 (Abstract).
  49. Sher G, Maassarani G, Zouves C, Feinman M, Matzner W, Ching W, Chong P. Recurrent IVF Failure and Antiphospholipid Antibodies; A Rational Basis for the use of Heparin/Aspirin and Intravenous Immunoglobulin G.  Xth World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May, 1997. (Poster).
  50. Sher G, Maassarani G, Zouves C, Feinman M, Matzner W, Ching W, Chong P. Selective Criteria for the Administration of Heparin/Aspirin alone or in combination with Immunoglobulin G in IVF patients with Antiphospholipid Autoantibodies Xth World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May, 1997 (Abstract).
  51. Sher G, Maassarani G, Zouves C, Feinman M, Matzner W, Ching W, Chong P. Improved pregnancy Rates in IVF patients with Organ-specific antithyroid antibodies, following treatment with IVIg.  Xth World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May, 1997 (Abstract).
  52. Zouves C, Sher G, Sohn S, Feinman,M, Maassarani G. Prediction and Prevention of severe Ovarian Hyperstimulation Syndrome.  Xth World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May, 1997 (Abstract).
  53. Sher G, Zouves C. “Optimizing Implantation: Diagnostic and Therapeutic Considerations”, A Textbook of In Vitro Fertilization and Assisted Reproduction: The Bourn Hall Guide to Clinical and Laboratory Practice’, Parthenon Publishing, 2nd, 275-283, 1999.
  54. Fisch JD, Rodriguez H, Ross R, Overby G, Sher G. Blastocyst formation following intracytoplasmic sperm injection (ICSI) of an oocyte without a zona pellucida.  Accepted in title for presentation at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, and CA. October 21-26, 2000.
  55. Fisch JD, Sher G, Maassarani G, Matzner W, Ching W, Chong P. Antibodies to Phosphatidylethanolamine and Phosphatidylserine correlate with increased Natural Killer Cell activity in non-male factor infertility patients.  Accepted in title for presentation at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, and CA. October 21-26, 2000.
  56. Rodriguez H, Ross R, Fisch JD, Sher G. A graduated embryo scoring (GES) system predicts blastocyst development from cleavage-stage embryos.  Poster presentation at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, CA. October 21-26, 2000.
  57. Fisch JD, Sher G. Sclerotherapy: A less invasive alternative for the treatment of ovarian endometriomas prior to IVF.  Poster presentation at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, CA, October 21-26, 2000.
  58. Fisch JD, Sher G. The antral follicle number on CD1 correlates with the number of MII oocytes. Poster presentation at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, CA, October 21-26, 2000.
  59. Fisch JD, Sher G. Colpohydrosonography (CHS) more accurately measures uterine cavity depth than conventional ultrasound.  Poster presentation at the 58th Annual meeting of the American society for Reproductive Medicine, Seattle, WA, October 12-17, 2002.
  60. Fisch JD, Sher G. The Antral Follicle Count (AFC) correlates with metaphase II oocytes and  ART cycle outcome: an update.  Oral presentation at the 58th Annual meeting of the American society for Reproductive Medicine, Seattle, WA, October 12-17, 2002.
  61. Fisch JD, Sher G. Vaginal Sildenafil improves ART outcome in a large cohort of patients  with multiple prior ART failures attributed to poor endometrial development.  Poster presentation at the 58th Annual meeting of the American society for Reproductive Medicine, Seattle, WA, October 12-17, 2002.
  62. Fisch JD, Sher G, Rodriguez H, Overby G, Adamowicz M, Keskintepe L. Graduated Embryo Score (GES) is superior to day-3 morphologic criteria alone for predicting ART outcome.  Poster presentation at the 58th Annual meeting of the American society for Reproductive Medicine, Seattle, WA, October 12-17, 2002.
  63. Fisch JD, Sher G, Maassarani G, Danner L. Intravenous Immunoglobulin G (IVIG) is associated with markedly improved IVF outcome in patients with elevated peripheral Natural Killer Cell activity (NKa+) and prior unexplained IVF failure.  Oral presentation at the 58th Annual meeting of the American society for Reproductive Medicine, Seattle, WA, October 12-17, 2002
  64. Fisch JD, Sher G, Keskintepe L. A randomized, controlled trial of low dose GnRH antagonist started on day 2 in poor responders undergoing stimulation with luteal phase GnRH agonist, estrogen priming and high-dose FSH.  Oral presentation at the 59th Annual  meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  65. Fisch JD, Sher G, Adamowicz M, Zody R, Keskintepe L. The Graduated Embryo Score  (GES) On Day 3 of Culture Predicts Outcome From Blastocyst Transfer. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  66. Fisch JD, Sher G. Sclerotherapy, a simple alternative to surgery for the treatment of ovarian endometriotic cysts in women scheduled to undergo IVF. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  67. Keskintepe L, Fisch JD, Adamowicz M, Zody R, Sher G. Transferring Embryos To Blastocyst Medium 36 Hrs Post ICSI in Preparation For Day 3 Embryo Transfer, Improves Implantation And Pregnancy Potential. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  68. Brusil I, Keskintepe L, Adamowicz M, Zody R, Fisch JD, Sher G. Predictive value of the  differential in Nucleolar Count (ND) between the pronuclei of 16 -18 hour zygote and  embryo quality on day 3 and 5. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-152003.
  69. Adamowicz M, Keskintepe L, Zody R, Danner L, Fisch JD, Sher G. Timing of blastocyst transfer relative to the thaw: A critical factor in outcome following FET. Poster presentation at the 59th Annual meeting of the American Society for Reproductive  Medicine, San Antonio, TX, October 11-15, 2003.
  70. Roussev R, Keskintepe L, Coulam C, Sher G, Maassarani G. Soluble HLA-G (sHLA-G) in human embryo culture media: A useful marker for assessing embryo quality, and implantation potential for IVF. Oral presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  71. Ahlering P, Keskintepe L, Fisch JD, Sher G, Danner L, Maassarani G. The Sperm DNA Integrity Assay (SDI™) a valuable method for assessing sperm vitality in preparation for In Vitro Fertilization (IVF). Oral presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  72. Adamowicz M, Keskintepe L, Zody R, Danner L, Fisch JD, Sher G. Timing of blastocyst transfer relative to the thaw: A critical factor in outcome following FET. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  73. Brusil I, Keskintepe L, Adamowicz M, Zody R, Fisch JD, Sher G. Distribution of nucleoli number and its correlation with embryo development. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  74. Keskintepe L, Machnicka A, Norris K, Pacholczyk G, Brackett BG, Sher G. High Incidence of Tetraploid Male Bovine Blastocyst Development from Oocytes injected with Sexed Freeze-Dried Spermatozoa. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  75. Coulam C, Ahlering P, Rodriguez H, Keskintepe L, Sher G, Maassarani G, Roussev R. Pregnancy Outcome after IVF/ET among Couples who have Elevated DNA Fragmentation Determined by the Sperm DNA Integrity Assay (SDI ™). Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  76. Sher G., Keskintepe L. (2004). Predictability of pregnancy and embryo implantation potential by measuring soluble HLA-G (sHLA-G) expression in the medium surrounding individual day 2 human embryos in culture. Presented at the ESHRE Meeting in Köln, Germany.
  77. Sher G, Keskintepe L.  Soluble HLA-G measurement in the medium surrounding individual day 2 embryos in culture: A strong predictor embryo implantation and viable pregnancy potential. Accepted for oral presentation at the ASRM Meeting in 2004, Philadelphia, Pennsylvania.
  78. Sher G, Keskintepe L.  A rational basis for measuring sHLA-G expression in culture media as a method for selecting embryos for transfer: A randomized, prospective study.  Accepted for oral presentation at the ASRM Meeting in 2004, Philadelphia, Pennsylvania.
  79. Keskintepe L., Sher G., Fisch JD., Zody R. (2005). Selecting no more than two embryos for day 3 ET on the basis of individual sHLA-G expression, enhances IVF outcome while eliminating high order multiple gestations.  Presented at the 13th World IVF Congress in Istanbul, Turkey.
  80. Keskintepe L., Sher G. , Batzofin J., Zody R. (2005). sHLAG-G measurement in the culture media is a good predictor for embryo quality on day 3 ET for women with elevated basal FSH level.  Presented at the 13th World IVF Congress in Istanbul, Turkey.
  81. Batzofin J., Keskintepe L, Sher G. (2005) Measurement of early embryo sHLA-G production: An improved method for assessing embryo “competency” and pregnancy generating potential following IVF.  Presented at the 13th World IVF Congress in Istanbul, Turkey.
  82. Keskintepe L, Sher G, Kotze, Adamowicz M. (2007). Blastocyst competency index provides powerful tool for selecting embryos on day 5 for fresh transfer and for the frozen embryo transfer cycle. Presented at 19th World Congress on Fertility and Sterility.
  83. Keskintepe L, Agca Y, Adamowicz M., Sher G. (2007) Effect of laser hatching on bovine oocytes before ultra rapid vitrification. Presented at 19th World Congress on Fertility and Sterility.
  84. Keskintepe M, Ginsburg M., Sher G, Keskintepe L. (2007) Whole genome amplification of polar bodies for embryo chromosome analysis by using a multiple displacement amplification (MDA) method.  Presented at 19th World Congress on Fertility and Sterility.
  85. Fisch JD., Worden C., Keskintepe L., Sher G. Graduated Embryo Score (GES) in the fresh cycle predicts outcome from frozen blastocyst transfer. Fertility and Sterility, September 2007 (Vol. 88, Page S246).
  86. Fisch JD., Adamowicz M., Jackworth J., Ginsburg M., Keskintepe L., Sher G. Single Embryo Transfer (SET) on day 3 versus day 5 based on Gruaduated Embryo Score (GES) and soluble Human Leukocyte Antigen-G (sHLA-G): Preliminary results of a prospective, randomized controlled trial.  Fertility and Sterility, September 2007 (Vol. 88, Page S315).
  87. Keskintepe L., Sher G., Ginsburg M., Keskintepe M., Okamoto P., Crowley J. A retrospective analysis of FISH “Normal” blastomeres in failed PGD cycles: A preliminary report.  Fertility and Sterility, September 2007 (Vol. 88, Page S237).
  88. Keskintepe L., Sher G., Agca Y., Adamowicz M., Maassarani M. Application of different oocyte vitrification protocols, laser assisted zona slitting, and temperature on post-warming survival of bovine oocyte. Fertility and Sterility, September 2007 (Vol. 88, Page S137).
  89. Sher G., Fisch JD., Keskintepe L. Vaginal sildenafil selectively improves uterine receptivity in women with poorly estrogenized endometrium. Fertility and Sterility, September 2007 (Vol. 88, Page S375).
  90. Sher G., Keskintepe L., Mukaida T., Keskintepe M., Ginsburg M., Maassarani G. Selective vitrification of euploid oocytes markedly improves their post-warming viability and post-fertilization pregnancy generating potential, thereby opening the door to commercial egg banking. Fertility and Sterility, September 2007 (Vol. 88, Page S343).
  91. Keskintepe L, Sher G, Agca Y, Adamowicz, Maassarani G (2007). Application of different oocyte vitrification protocols, laster assisted zona slitting, and temperature on post-warming survival of bovine oocyte. Fertility and Sterility September (Vol. 88, Page S349)
  92. Kotze D J, Anderson S C, Keskintepe L, and Greene R, Sher G (2008) Deceptive appearances: moving beyond morphology in embryo selection. A picture is not worth 23 chromosomes. Fertility and Sterility; September (Vol. 90, Page S372).
  93. Keskintepe, Bayrak A, Sher G (2008). Multiple interventions did not cause any harmful affect on chromosomally normal donor embryos: case study. Fertility and Sterility; September (Vol. 90, Page S279).
  94. Sondeno R, Keskintepe M, Ginsburg M, Okomoto P, Sher G, Keskintepe (2008). Embryo development rate may be affected by chromosomal constitution of an embryo. Fertility and Sterility. September (Vol. 90) Page S298).
  95. Keskintepe L, Agca Y, Bayrak A, Sher G (2009), Effective human and mouse blastocycst vitrification system: introducing Cryopette Fertility and Sterility. September 2009 (Vol. 92, Issue 3, Page S24)

 

PRESENTATIONS AT SCIENTIFIC MEETINGS

  1. Sher G. “Inadequate Cervical Mucus – a Cause of Idiopathic Infertility”, 18th South African Congress of Obstetrics and Gynecology, Durban, South Africa, September 1976.
  2. Sher G. “Accidental Hemorrhage with Severe Coagulopathy and Maternal Prognosis”, 18th South African Congress of Obstetrics and Gynecology, Durban, South Africa, September 1976.
  3. Sher G. “Therapeutic Midtrimester Abortion by the Intrauterine Administration of Prostaglandins,” 18th South African Congress of Obstetrics and Gynecology, Durban, South Africa, September 1976.
  4. Sher G. “Intra-amniotic Use of Urea and Prostaglandin F2Alpha to Induce Labor in Pregnancies Complicated by the Death of the Fetus”, 18th South African Congress of Obstetrics and Gynecology, Durban, South Africa, September 1976.
  5. Sher G. “Thromboembolism and the Pill”, (Invited Speaker) South African Society of Obstetrics-Gynecology, Belville, Cape Town, 1976.
  6. Sher G. “Pathogenesis and Management of Abruptio Placentae”, Southeastern Perinatal Research Meeting, Jacksonville, Florida, March 1977.
  7. Sher G. “Pathogenesis and Management of Abruptio Placentae”, North Carolina Junior Fellows of ACOG, Winston-Salem, North Carolina, March 1977.
  8. Sher G. “Surgical Management of Lower Urinary Tract Fistulae,” North Carolina.
  9. Sher G. “Diagnosis and Management of Lower Urinary Tract Fistulae”, ACOG Seminar, Asheville, North Carolina, May 1977.
  10. Sher G. “Minidose Heparin in Gynecological Surgery”, ACOG Seminar, Asheville, North Carolina, May 1977.
  11. Sher G. “A Rational Approach to the Management of Abruptio Placentae”, ACOG Seminar, Asheville, North Carolina, July 1977.
  12. Sher G. “Predicting Fetal Lung Maturity”, Robert A. Ross Society, Annual Meeting, Chapel Hill, North Carolina, October 1977.
  13. Statland BE, Freer DE, Sher G. “Role of Ethanol Volume Fraction in Determining the Formation of Stable Foam in Amniotic Fluid”, Tenth International Congress of Clinical Chemistry, Mexico City, February, 1978.
  14. Freer DE, Statland BE, Sher, G. “Clinical Evaluation of a Modified Amniotic Fluid Foam Stability Test for the Determination of Fetal Pulmonary Maturity”: Tenth International Congress of Clinical Chemistry, Mexico City, February 1978.
  15. Sher G. “The Foam Stability Index (FSI) – Test”, SGI Annual Meeting, Atlanta, Georgia, March 1978 (by title).
  16. Sher G. “Evaluation of a Sensitive and Rapid Test of Functional Surfactant Activity (The FS-50 Test)”, ACOG Annual Clinical Meeting, Anaheim, California, April 1978.
  17. Sher G. “Foam Stability Index (FSI) – Test”, North Carolina Junior Fellows of ACOG, Chapel Hill, North Carolina, April 1978.
  18. Sher G. “Pathogenesis of Premature Labor and Its Management”, ACOG Postgraduate Course, Asheville, North Carolina, May 1978.
  19. Sher G. “Pharmacologic Enhancement of Fetal Lung Maturity – The Beta-Methasone Controversy”, Endocrine and Infertility ACOG Seminar, Asheville, North Carolina, May 1978.
  20. Sher G. “Plasma Versus Urinary Estrogens or HPL for Prenatal Monitoring of High Risk Gestations”, Endocrine and Infertility ACOG Seminar, Asheville, North Carolina, May 1978.
  21. Sher G, Statland BE, Sher G, Freer DE. “The Evolution of A Simple, Reliable, Quantitative Foam Stability Assay of Amniotic Fluid Surfactant”, 4th International Colloquium of Prospective Biology, France, 1978.
  22. Sher G. “Abruptio Placentae and Consumption Coagulopathy”, 5th International Symposium, Kinins, Japan, 1978.
  23. Sher G. “Abruptio Placentae with Consumption Coagulopathy and Uterine Inertia: Therapeutic Effect of Parenteral Infusion of Trasylol in Uterine Contractility”, Shock Symposium, Tokyo, Japan, November 1978.
  24. Sher G. “The Foam Stability Index (FSI) – Test, for the Prenatal Assessment of Fetal Pulmonary Maturity”, April, 1979, National ACOG Annual Meeting, New York.
  25. Sher G. “Evaluation of the Foam Stability Index (FSI) – Test”, September 1979, District VIII ACOG Meeting, Seattle, Washington.
  26. Sher G. “Evaluation of the Foam Stability Index (FSI) – Test”, October 1979 Ninth World Congress of the International Federation of Obstetricians and Gynecologists (FIGO), Japan.
  27. Sher G. “Management of Uterine Inertia Associated With Abruptio Placentae and Consumption Coagulopathy”, November 1979, Ninth World Congress of the International Federation of Obstetrics and Gynecologists (FIGO), Japan.
  28. Sher G. “Management of D.I.C. Associated with Abruptio Placentae”, November 1979, Symposium on Shock in Obstetrics, Royal Hotel, Osaka, Japan.
  29. Sher G “Abruptio Placentae and Consumption Coagulopathy”, Bayer Symposium on Obstetric      Shock, International Symposium on Proteases and Anti-Proteases, Dubrovnik, Yugoslavia, 1980
  30. Sher G. Abruptio Placentae and Consumption Coagulopathy”, Bayer Symposium on Obstetric      Shock, International Symposium on Proteases and Anti-Proteases, Dubrovnik, Yugoslavia, 1980 
  31. Sher G. “Diagnostic Effectiveness of the Amniotic Fluid Foam Stability Index (FSI) – Test”, District VIII ACOG Meeting, San Diego, California, October 1981.
  32. Sher G. “Genetics in the Evolution and Management of High Risk Pregnancies”, 3rd Symposium on Genetics in Health and Disease, University of Nevada, Reno, November 1981.
  33. Sher G. “D.I.C. – Related Obstetric Problems Diagnosis and Management”, Symposium on Obstetrics Hemorrhage, Tokyo Prince Hotel, Tokyo, Japan, November 1981.
  34. Ito R, Statland BE, Sher G, Knutzen, VK. “Assaying Plasma Prekallikrein (PPK) By a Chromogenic-Based Method: Analytical Considerations and Reference Values in Healthy Adults, and Pregnant Women, and the Neonate”, Proceedings of the International Kinin Symposium, Munich, Germany, November 1981.
  35. Stratton CJ, Sher G, Vaught LK. “The Effects of Human Placental Lactogen, Prolactin, Morphine Sulfate and Other Drugs on Mammalian, Fetal Surfactant Production”, Annual Meeting of the District VIII ACOG, San Diego, California, October/November 1981.
  36. Sher G, Statland BE, Knutzen VK. “Clinical Evaluation of the Amniotic Fluid foam Stability Index (FSI) – Test in Normal and High Risk Pregnancies”, Annual Meeting of the District VIII ACOG, San Diego, California, October/November 1981.
  37. Sher G. “Clinical Evaluation of Quantitative Amniotic Fluid Foam Stability Index (FSI) – Test for Prenatal Assessment”, Seventh Annual District VIII Section of Perinatal Pediatrics Meeting, May 1982, Jackson, Wyoming.
  38. Sher G. “An Important Role for the Quantitative Amniotic Fluid Foam Stability Index (FSI) – Test in Management of the High Risk, Small, Third-Trimester Fetus (STF) – A Prospective Study”, Seventh Annual District VIII Section of Perinatal Pediatrics Meeting, May 1982, Jackson Wyoming.
  39. Sher G, Statland BE, Painter PC. “Methods of Evaluating Fetal Lung Maturity”, 34th National Meeting, American Association of Clinical Chemists, August 1982, Anaheim, California.
  40. Sher G, Statland BE, Knutzen VK. “Concurrent Measurements of Fetal Biparietal Diameter (BPD) and Amniotic Fluid Foam Stability Index (FSI)”, October 1982, Tenth World Congress of Gynecology and Obstetrics (FIGO), San Francisco.
  41. Sher G, Statland BE, Knutzen VK. “Clinical Evaluations of Amniotic Fluid Foam Stability Index (FSI) – Test”, October 1982, Tenth World Congress of Gynecology and Obstetrics (FIGO), San Francisco, October 1982.
  42. Sher G, Statland BE, Knutzen VK. “The Kallikrein Kinin System in Normal Pregnancy”, Tenth World Congress of Gynecology and Obstetrics (FIGO), San Francisco, October 1982.
  43. Sher G, Statland BE. “Management of the High-Risk, Small, Third-Trimester Fetus – Recent Advances in the U.S.A.”, September 1982, 30th Annual Meeting of Northern Japan, Society of Obstetrics and Gynecology, Akita, Japan.
  44. Sher G, Statland BE, Knutzen VK. “Clinical Utility of the Amniotic Fluid Foam Stability Index (FSI) – Test”, October 1982, Meeting of District VIII ACOG, Vancouver, Canada.
  45. Sher G, Statland BE, Knutzen VK. “The Kallikrein-kinin System in Normal Pregnancy”; October 1982, District VIII ACOG Meeting, Vancouver, Canada.
  46. Sher G, Statland BE, Painter PC. “Methods of Evaluating Fetal Pulmonary Maturity”; October 1982, Fall Meeting of the American Society of Clinical Pathologists, Miami, Florida.
  47. Sher G, Statland BE, Knutzen VK, Ito R. “The Kallikrein-kinin System in Normal Pregnancy”; Tenth World Congress of Gynecology and Obstetrics, October 1982, San Francisco, California.
  48. Sher G, Statland BE, Knutzen VK. “Concurrent Measurements of Fetal Biparietal Diameter and Amniotic Fluid Foam Stability Index Test”; Tenth World Congress of Gynecology and Obstetrics, October 1982, San Francisco, California.
  49. Sher G, Statland BE, Knutzen VK. “Clinical Evaluation of the Amniotic Fluid Foam Stability Index Test”; Tenth World Congress of Gynecology and Obstetrics, October 1982, San Francisco, California.
  50. Stratton CJ, Montakhab MM, Sher G. “Extracorporeal Human Sperm Capacitation: Ultra structural Analysis”; Annual American Association of Anatomists, Seattle, Washington, April 11, 1984.
  51. Sher G, Knutzen VK, Stratton CJ, Montakhab MM. “Successful Management of Refractory Infertility through Transcervical Insemination of Human Spermatozoa Capacitated In Vitro”; Third World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984.
  52. Stratton CJ, Montakhab MM, Sher G, Knutzen VK. “Extracorporeal Human Sperm Capacitation: Ultra structural Analysis”; Third World Congress of InVitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984.
  53. Montakhab MM, Stratton CJ, Sher G, Knutzen, VK. “A Possible Role for Coronal Radiata in Promoting In Vitro Fertilization of Human Pre-Ovulatory Oocytes”; Third World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984.
  54. Sher G, Knutzen VK, Stratton CJ, Montakhab MM. “Comparative Evaluation of Progesterone Therapy and HCG Administration for the Enhancement of Corpus Luteum Function”; Third World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984.
  55. Sher G, Knutzen VK, Stratton CJ, Chotiner HC, Montakhab MM. “Successful In Vitro Fertilization/Embryo Transfer in Association with A Private (Non-University Based) Practice”; Third World Congress of In Vitro Fertilization and Embryo Transfer, Helsinki, Finland, May 1984.
  56. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. “Possible Factors Contributing to the High Success Rate with In Vitro Fertilization and Embryo Transfer”; Annual Meeting of American Society of Gynecologic Laparoscopists, Las Vegas, Nevada, November 1984.
  57. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. “In Vitro Sperm Capacitation and Transcervical Intrauterine Insemination for the Management of Refractory Non-Organic Infertility”; Annual Meeting of American Society of Gynecologic Laparoscopists, Las Vegas, Nevada, November, 1984.
  58. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. “Augmentation of Corpus Luteum Insufficiency Following In Vitro Fertilization and Embryo Transfer with Parenteral Human Chorionic Gonadotropin”; Annual Meeting of American Society of Gynecologic Laparoscopists, Las Vegas, Nevada, November 1984.
  59. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. “Endocervical Embryo Sequestration – A Possible Cause of Failure Following In Vitro Fertilization and Embryo Transfer”; Annual Meeting of American Society of Gynecologic Laparoscopists, Las Vegas, Nevada, November 1984.
  60. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. “Management of Non-Organic Female Infertility by Transcervical Insemination of Sperm Capacitated In Vitro”; Guest Speaker – Combined Royal Fertility Society and Canadian Fertility Society Meeting, September 1984, Vancouver, Canada.
  61. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. “Factors contributing Toward the Successful Establishment of an IVF/ET Program in Private Practice in the USA.” Proceedings of the Combined Royal Fertility and Canadian Fertility Society Meeting, September 1984, Vancouver, Canada – Published in the Journal of Obstetrics and Gynecology, January 1985.
  62. Sher G, Knutzen VK, Stratton CJ, Chotiner HC. Factors Contributing Toward the Successful Establishment of an IVF/ET Program in Private Practice in the U.S.A.; Proceedings of the Combined Royal Fertility and Canadian Fertility Society Meeting, September 1984, Vancouver, Canada – Published in the Journal of Obstetrics and Gynecology, January 1985.
  63. Sher G. Evaluation of Three Procedures Employed by the Northern Nevada Fertility Center Laboratory, Which Differ From Other Clinics; Fourth World Conference on In Vitro Fertilization, Melbourne, Australia, November 1985.
  64. Sher G. “Factors Contributing Toward Success in In Vitro Fertilization and Embryo Transfer”; ACOG District VIII Meeting, Reno, Nevada, 1985.
  65. Sher G. “Clinical Aspects of In Vitro Fertilization”, American Medical Association of Technologists, February 1986, Las Vegas, Nevada.
  66. Sher G. “Clinical Aspects of In Vitro Fertilization”, 99th Annual Meeting of American Association of Anatomists, Reno, Nevada, March 1986.
  67. Sher G, Knutzen VK. Institution of Rigid Protocols and Quality Assurance in an IVF/ET Program, “The Team Approach to In Vitro Fertilization”, Reno, Nevada,
    June 1987.
  68. Sher G, Knutzen VK. The Pergonal (HMG) Regimen used for Controlled Ovarian Hyperstimulation at Northern Nevada Fertility Center, “The Team Approach to In Vitro Fertilization”, June 1987, Reno, Nevada.
  69. Knutzen VK, Sher G. Designing and Staffing an IVF Program, “The Team Approach to In Vitro Fertilization”, June 1987, Reno, Nevada.
  70. Knutzen VK, Sher G. The Selection of the Ideal IVF Candidate, “The Team Approach to In Vitro Fertilization”, June 1987, Reno, Nevada.
  71. Knutzen VK, Sher G. Laparoscopic Oocyte Retrieval: Technical Consideration “The Team Approach to In Vitro Fertilization”, June 1987, Reno, Nevada.
  72. Sher G, Knutzen VK. “Oocyte Cryopreservation,” Annual Meeting of American Fertility Society, September 1987, Reno, Nevada.
  73. Sher G, Knutzen VK. Hormonal Changes Associated with Controlled Ovarian Hyperstimulation in preparation for IVF/ET, Annual Meeting of American Fertility Society, September 1987, Reno, Nevada.
  74. Sher G, Vaught WG, Vaught LK, Knutzen VK. The Comparative Effect of hCG Versus Progesterone Administration in the Luteal Phase or Corpus Luteum Function as Judged by Luteal Phase Plasma Progesterone and Estradiol Concentrations and the Length of the Luteal Phase; 6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, April, 1989, Jerusalem, Israel.
  75. Sher G, Vaught WG, Vaught LK, Knutzen VK. The Influence of Age, Uterine Length, Pre-Post Egg Retrieval Plasma Estradiol Drop, and the Number of Cleaved Embryos Transferred to the Uterus – on Outcome Following IVF/ET. 6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, April, 1989, Jerusalem, Israel.
  76. Knutzen VK, Soto-Albors C, Fuller D, Sher G, Shyrock K, Behr B. Mock Embryo Transfer (MET) In Early Luteal Phase the Cycle Prior to In Vitro Fertilization and Embryo Transfer (IVF/ET): A Preliminary Report, 6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, April 1989,
    and Jerusalem, Israel.
  77. Stratton CJ, Knutzen LAL, Montakhab MM, Knutzen VK, Sher G, Julian P, Behr B, Vaught LK, Vaught WG. The Introduction of 27-1/2 g Needle Removal (Peeling) Of The Sperm-Hardened Coronal Cells from the Human Embryo:  6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, April, 1989, Jerusalem, Israel.
  78. Knutzen LAL, Stratton CJ, Knutzen VK, Sher G, Behr B, Julian P, Vaught LK, Vaught WG, Melarkey D. Evaluation of Lumen Parameters of Various Catheters Contracting Human Ovas and Embryos; 6th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, April, 1989, Jerusalem, Israel.
  79. Foote WD, Vaught LK, Knutzen VK, Sher G. Initiation of early cleavage and increased overall cleavage rate of mouse embryos using IVF.  43rd Annual Meeting of the American Fertility Society, 1987.
  80. Sher G, Knutzen VK. Assessment of variables that impact on success rate following IVF/ET; 6th World Congress of In Vitro Fertilization and Embryo Transfer, April 1989, Jerusalem, Israel.
  81. Sher G, Knutzen VK. Intrauterine insemination with transperitoneal insemination, an analysis of outcome comparing various methods of controlled ovarian hyperstimulation, 6th World Congress of InVitro Fertilization and Embryo Transfer, April 1989, Jerusalem, Israel.
  82. Sher G, Cohen N, Knutzen V.K. Enhanced Sonographic Resolution in the Applied Management of Reproductive Disorders; Society of Gynecologic Laparoscopists, June, 1991, Chicago, Illinois.
  83. Sher G. Ultrasound Status of the Endometrium — Relationship to Stimulation and Pregnancy following In Vitro Fertilization and Embryo Transfer (IVF/ET).  4th Annual In Vitro Fertilization and Embryo Transfer, Santa Barbara, California, July 1991.
  84. Sher G, Cohen N, Knutzen VK. Next Generation Ultrasound.  World Congress of Gynecologic Endoscopy AAGL 20th Annual Meeting, Las Vegas, Nevada, November 1991.      
  85. Sher G, Knutzen VK. Suboptimal Endometrial Patterns on Transvaginal Ultrasound Scanning. Vth Annual InVitro Fertilization and Embryo Transfer, Santa Barbara, California, July 1992.
  86. Sher G, Knutzen V. Comparing Methods of Controlled Ovarian Hyperstimulation (COH) with Outcome in Women Undergoing Intrauterine Insemination (IUI) and Transperitoneal Insemination (IUI). Vth Annual InVitro Fertilization and Embryo Transfer, Santa Barbara, California, July 1992.
  87. Sher G. A New Approach to the Management of Severe Ovarian Hyperstimulation (OH) which Eliminates the Need for Cancellation of the Treatment Cycle.  The International Congress of Gynecologic Endoscopy, AAGL 21st Annual Meeting, Chicago, Illinois, September 1992.
  88. Sher G, Cohen N, Knutzen V. Next Generation Ultrasound (NGU).  The International Congress of Gynecologic Endoscopy AAGL 21st Annual Meeting, Chicago, Illinois, September 1992.
  89. Sher G, Salem R. Eliminating Complications associated with Severe Ovarian Hyperstimulation in Patients Receiving Menotropins for IVF/ET.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 12 – 15, 1993.
  90. Sher G, Knutzen V, Zouves C. Suboptimal Sonographic Late Proliferative phase Endometrial Patterns in Patients Undergoing IVF.  VIIIth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan,
    September 12 – 15, 1993.
  91. Sher G. Preparation and Assessment of the Endometrium for Implantation Following In-Vitro Fertilization and Embryo Transfer.  AAGL 22nd Annual Meeting, November 10 – 14, 1993, San Francisco, California.
  92. Sher G. Choice, Control, and Responsibility in Genetic Manipulation: Designs on Life. The International Bioethics Institute presents the Fourth Annual Congress of Healthcare Ethics and Ethics Committees, Co-Sponsored by The School of Public Health, University of California, and Berkeley.  April 15 – 17, 1994, San Francisco, California.
  93. Sher G. “How to Select and Use the Most Appropriate Fertility Agents in the Treatment of Infertility” (Roundtable Talk).  International Congress of Gynecologic Endoscopy, AAGL 23rd Annual Meeting, New York, New York.  October 18 – 23, 1994. 
  94. Sher G. “Medical & Ethical Aspects of Third-Party Parenting”.  Torrance Memorial Medical Center, Torrance, California.  February 15, 1995. 
  95. Sher G.  “Establishing ethical criteria for assisted reproductive Technologies (ART)”.  In vitro Fertilization (Symposium). University of California, Berkeley, July, 1995
  96. Sher G, Feinman M. “Presentation the Day-to-Day Realities:  Commentary on the New Eugenics and Medicalized Reproduction”.  Eugenics and the new Reproductive Technologies (Congress). International symposium on Bioethics in Reproduction, July, 1995 San Francisco, CA.
  97. Sher G. “Pre-Implantation Genetic Diagnosis: Ethical and Medical Implications”; Presentation to select committee.  California State Senate, April, 1996.
  98. Sher G. “Optimizing Implantation with IVF: Diagnostic and Therapeutic Considerations” American Society of Reproductive Medicine (ASRM) [Annual Meeting- Postgraduate course], October 1996.
  99. Sher G. “Accountability, Representation and Advertising in Reproductive Medicine” [Annual Meeting] National Association of Bioethics in Reproduction, September, 1996 Washington, D.C.
  100. Sher G. Improved pregnancy Rates in IVF patients with Organ-specific antithyroid antibodies, following treatment with IVIg. Xth World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May, 1997.
  101. Sher G. Selective Criteria for the Administration of Heparin/Aspirin alone or in combination with Immunoglobulin G in IVF patients with Antiphospholipid Autoantibodies. Xth World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May, 1997.
  102. Sher G. A Rational Basis for Selective Immunotherapy in IVF patients testing seropositive to Autoantibodies Xth World Congress on In Vitro Fertilization and Assisted Reproduction, Vancouver, Canada, May, 1997.
  103. Sher G. A Rational Basis for the Introduction of Universal Infertility Insurance Coverage in the United States, Symposium on Insurance Reimbursement for ART; Organon Pharmaceuticals, Boston, MA, August 2000.
  104. Fisch JD, Rodriguez H, Ross R, Overby G, Sher G. Blastocyst formation following intracytoplasmic sperm injection (ICSI) of an oocyte without a zona pellucida. 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, CA. October 21-26, 2000.
  105. 105. Fisch JD, Sher G, Maassarani G, Matzner W, Ching W, Chong P. Antibodies to Phosphatidylethanolamine and Phosphatidylserine correlate with increased Natural Killer Cell activity in non-male factor infertility patients.  56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, CA. October 21-26, 2000.
  106. Fisch JD, Sher G. The Antral Follicle Count (AFC) correlates with metaphase II oocytes and ART cycle outcome: an update. 58th Annual meeting of the American society for Reproductive Medicine, Seattle, WA, October 12-17, 2002.
  107. Fisch JD, Sher G, Maassarani G, Danner L. Intravenous Immunoglobulin G (IVIG) is associated with markedly improved IVF outcome in patients with elevated peripheral Natural Killer Cell activity (NKa+) and prior unexplained IVF failure. 58th Annual meeting of the American society for Reproductive Medicine, Seattle, WA, October 12-17, 2002.
  108. Fisch JD, Sher G, Keskintepe L. A randomized, controlled trial of low dose GnRH antagonist started on day 2 in poor responders undergoing stimulation with luteal phase GnRH agonist, estrogen priming and high-dose FSH.  59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  109. Brusil I, Keskintepe L, Adamowicz M, Zody R, Fisch JD, Sher G. Predictive value of the differential in Nucleolar Count (ND) between the pronuclei of 16 -18 hour zygote and embryo quality on day 3 and 5. Poster presentation at the 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  110. Roussev R, Keskintepe L, Coulam C, Sher G, Maassarani G. Soluble HLA-G (sHLA-G) in human embryo culture media: A useful marker for assessing embryo quality, and implantation potential for IVF. Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  111. Ahlering P, Keskintepe L, Fisch JD, Sher G, Danner L, Maassarani G. The Sperm DNA Integrity Assay (SDI™) a valuable method for assessing sperm vitality in preparation for In Vitro Fertilization (IVF). 59th Annual meeting of the American Society for Reproductive Medicine, San Antonio, TX, October 11-15, 2003.
  112. G. Sher, L. Keskintepe (2004). Predictability of pregnancy and embryo implantation potential by measuring soluble HLA-G (sHLA-G) expression in the medium surrounding individual day 2 human embryos in culture. Presented at the ESHRE Meeting in 2004 in Köln, Germany.
  113. Sher G, Keskintepe L.  Soluble HLA-G measurement in the medium surrounding individual day 2 embryos in culture: A strong predictor embryo implantation and viable pregnancy potential. 60th ASRM Meeting in 2004, Philadelphia, Pennsylvania.
  114. Sher G, Keskintepe L.  A rational basis for measuring sHLA-G expression in culture media as a method for selecting embryos for transfer: A randomized, prospective study.  60th ASRM Meeting in 2004, Philadelphia, Pennsylvania.
  115. L. Keskintepe, G. Sher, JD. Fisch, R. Zody (2005). Selecting no more than two embryos for day 3 ET on the basis of individual sHLA-G expression, enhances IVF outcome while eliminating high order multiple gestations.  Presented at the 13th World IVF Congress in Istanbul, Turkey.
  116. L. Keskintepe, G. Sher, J. Batzofin, R. Zody (2005). sHla-G measurement in the culture media is a good predictor for embryo quality on day 3 ET for women with elevated basal FSH level.  Presented at the 13th World IVF Congress in Istanbul, Turkey.
  117. J. Batzofin, L. Keskintepe, G. Sher (2005). Measurement of early embryo sHLA-G production: An improved method for assessing embryo “competency” and pregnancy generating potential following IVF.  Presented at the 13th World IVF Congress in Istanbul, Turkey.
  118. Keskintepe L, Sher G, Kotze, Adamowicz M. (2007). Blastocyst competency index provides powerful tool for selecting embryos on day 5 for fresh transfer and for the frozen embryo transfer cycle. Presented at 19th World Congress on Fertility and Sterility.
  119. Keskintepe L, Agca Y, Adamowicz M., Sher G. (2007) Effect of laser hatching on bovine oocytes before ultra rapid vitrification. Presented at 19th World Congress on Fertility and Sterility.
  120. Keskintepe M, Ginsburg M., Sher G, Keskintepe L. (2007) Whole genome amplification of polar bodies for embryo chromosome analysis by using a multiple displacement amplification (MDA) method.  Presented at 19th World Congress on Fertility and Sterility.
  121. Keskintepe L., Bayrak A., Sher G. (2008). Multiple interventions did not cause any harmful affect on chromosomally normal donor oocytes: case study.  Submitted to the 64th ASRM Meeting.
  122. Sondeno R., Keskintepe M., Ginsburg M., Okomoto P., Sher G., Keskintepe L. (2008) Embryo development rate is affected by chromosomal constitution of an embryo. Submitted to the 64th ASRM Meeting.
  123. Kotze DJ., Anderson S., Keskintepe L., Greene R., Sher G. (2008). Blastocyst by its morphology: a picture is not worth 23 chromosomes. Submitted to the 64th ASRM Meeting.
  124. Sher G.    One Embryo – One Baby: Keynote speaker at the Obstetrical Society of Philadelphia; November 2009

BOOKS AUTHORED

  1. Sher G, Knutzen VK.  “Your Pregnancy”; Co-Authors Lay Press Publication. 
    A Walaby Book Published by Simon and Schuster, New York, 1983.
  2. Sher G. “From Infertility to In Vitro fertilization”; McGraw-Hill Publishing, New York, 1988.
  3. Sher G. “In Vitro Fertilization: The A.R.T. of Making Babies”; Facts on File, New York, 1998.
  4. Sher G. “In Vitro Fertilization: The A.R.T. of Making Babies” 3rd edition – 2005
  5. Sher G. “IVF: The SIRM Way” – 2008
  6. Sher G. “In Vitro Fertilization: The A.R.T. of Making Babies” 4th edition – 2013

RESEARCH PROJECTS

  1. Evaluation of a new assay, the Foam Stability Index (FSI) – Test for the Prenatal Evaluation of Fetal Pulmonary Maturity. This study was taken to the stage of commercial viability and led to the development of the Lumadex-FSI test which was marketed worldwide by Beckman Instruments.  This bedside assay is currently one of the most widely used tests of its kind in the world.
  2. The Establishment of the 1st private (non University-based) In vitro Fertilization Program in the United States.
  3. In Vitro Sperm Capacitation and Transcervical Intrauterine Insemination for Treating Non-organic Female Infertility. This process first introduced and described by Dr. Sher et al in 1984 has gained worldwide acceptance as a method of choice for the treatment of infertility unrelated to female organic pelvic disease.
  4. Identification of the sonographic appearance of the endometrium in the late proliferative phase as an index of outcome in patients undergoing in vitro fertilization and embryo transfer (IVF/ET). This study, the first of its kind, firmly identified ultrasound sonographic appearance prior to egg retrieval as an important prognostic variable in assessing outcome following IVF/ET.
  5. The development of unique ultrasound technology which improves sonographic resolution by a factor of 5 and reduces noise by 95%. This project developed by Dr. Sher and Nathan Cohen, Ph.D., of the Department of Radio Astronomy at Boston University was recently patented.  The method, which is being heralded as a major breakthrough in the field of diagnostic imaging, has the potential of revolutionizing the ultrasound industry with enormous commercial potential.
  6. The development of an immortal human granulosa cell line for the purpose of assessing the biopotency of endogenous and exogenous gonadotropins, for toxicologic studies, and for the genesis of ovarian steroids in culture. This study conceived by Dr. Sher and pioneered by Janice Brothers, Ph.D., is under patent review and has significant commercial applications.  It represents the first successful attempt at maintaining one cell line of human granulosa cells, to date.
  7. An in-depth evaluation of the effect of autoimmune antibodies on implantation following in vitro fertilization and embryo transfer. This study examined the incidence of antiphospholipid antibody (APA) seropositivity in IVF candidates and the potential effect on pregnancy rates in APA seropositive individuals.
  8. Sher Institute for Reproductive Medicine, Las Vegas, NV. A prospective randomized evaluation of Heparin Immunoglobulin G (IVIG) therapy on implantation and ongoing pregnancy rates following IVF in antiphospholipid antibody (APA) positive women with increased peripheral blood Natural Killer (NK) cell activity.  Supported by a grant from Serono Inc.
  9. Sher Institute for Reproductive Medicine, Las Vegas, NV. An evaluation of Intralipid (IL) therapy on implantation and ongoing pregnancy rates following IVF in women with increased peripheral blood Natural Killer (NK) cell activity.  (Self-funded)
  10. Sher Institute for Reproductive Medicine, Las Vegas, NV. Comparison of Lupron with Lupron/Antagon for treatment of women experiencing low response to gonadotropins during IVF/ET cycles.  Supported by a grant from Organon Inc.
  11. Sher Institute for Reproductive Medicine, Las Vegas, NV. Prospective Randomized Controlled Multicenter Trial comparing a new recombinant FSH preparation to Gonal-F and Fertinex for ovarian stimulation for IVF.  Supported by a grant from Serono Inc.
  12. Sher Institute for Reproductive Medicine, Las Vegas, NV. Prospective Randomized Controlled Trial comparing recombinant LH to FSH alone for ovarian stimulation in IVF.  Supported by a grant from Serono Inc.
  13. Administration of GnRH antagonist (Cetrorelix – Asta/Serono Laboratories) in combination with rFSH (Gonal-f – Serono Laboratories) versus Cetrorelix/Gonal-f with rLH (Lhadi – Serono Laboratories) to “poor responder patients” undergoing in vitro fertilization and embryo transfer at the Sher Institute for Reproductive Medicine (SIRM).
  14. A prospective, randomized, evaluation of Heparin-Immunoglobulin (IVIG) therapy on implantation and ongoing pregnancy rates following In Vitro Fertilization in Antiphospholipid Antibody (APA) positive women with increased peripheral blood natural killer cell activity.
  15. Controlled ovarian hyperstimulation using low-dose gonadotropins and intrauterine insemination performed by reproductive endocrinologist-supervised, general obstetrician/gynecologists.
  16. Pituitary down-regulation with Lupron (“long protocol) versus antagon pituitary “blockade” in normal gonadotropin responders undergoing IVF.
  17. Comparison of Lupron with Lupron/Antagon for treatment of women experiencing low response to gonadotropins during IVF/ET cycles.
  18. Soluble HLA-G (sHLA-G) expression in human embryo culture media: A marker for embryo quality assessment.
  19. To test the efficacy and economic efficiency of natural cycle IVF or non-GNRHa, minimal stimulation cycles in a select population of patients.
  20. Oocyte Karyotyping by Comparative Genomic Hybridization for Selecting “Competent” Embryos
  21. Selective Vitrification of Euploid Oocytes: Impact on Donor Oocyte Banking, Fertility Preservation (FP) and IVF outcome
  22. Sher Institute for Reproductive Medicine, Las Vegas, NV. A prospective evaluation of Comparative Genomic Hybridization (CGH) for identifying embryos that are most likely to propagate viable pregnancies in IVF
  23. Staggered in Vitro Fertilization (S-IVF): A process involving selective vitrification of euploid oocytes followed by warming, ICSI and embryo transfer performed in a subsequent hormone replacement cycle.
  24. Hindsight Embryo Karyotyping (HSK). A process that affords Diagnostic information regarding the cause of Reproductive failure
  25. Development of a “Genetic Embryo Bank” for: Banking vitrified , karyotyped oocytes for : Egg donation, Fertility Preservation, Fertility Rescue